Aldose Reductase Inhibitors for Diabetic Cataract: A Study of Disclosure Patterns in Patents and Peer Review Papers

Journal Title: Ophthalmology Research: An International Journal - Year 2014, Vol 2, Issue 3

Abstract

Aims: To investigate, for 13 aldose reductase inhibitors that had been in development for diabetic cataract, whether patent documents could provide earlier dissemination of knowledge to the ophthalmology community than peer review papers. Methodology: Searches for intellectual property disclosures were conducted in our internal database of ophthalmology patent documents, and were supplemented by online searches in the public Espacenet and Google Patents databases. Searches for peer review papers were performed in Pub Med and Google Scholar, and in our internal database of machine-readable ophthalmology publications. Results: For sorbinil, tolrestat, fidarestat and GP-1447 patent documents clearly preempted the peer review literature in terms of data-supported information on potential effectiveness in diabetic cataract, typically by 7-17 months. For alrestatin, zenarestat, zopolrestat, indomethacin, and quercitrin academic journals were clearly first to properly report this therapeutic utility, preempting the corresponding patents by 6 months to several years. For ponalrestat, risarestat, epalrestat, and lidorestat claims of utility in diabetic cataract were first made in patent documents, but with insufficient or incomplete support. Conclusion: Our results suggest that including patent documents in the routine monitoring of newly disclosed knowledge could significantly improve the comprehensiveness of the literature base in ocular pharmacology, and has the potential to alert researchers to emerging drug candidates earlier than reports in the peer review literature.

Authors and Affiliations

H. A. M. Mucke, E. Mucke, P. M. Mucke

Keywords

Related Articles

My Experience with Levator Resection Surgery in Congenital Ptosis

Aims: To assess the effectiveness of Levator resection surgery in patients with moderate to severe congenital ptosis with poor Levator function. Materials and Methods: Settings and Design: A prospective, observational, s...

Employing the Intraocular Irrigating Solution Containing Moxifloxacin in Cases of Posterior Capsular Rupture

Introduction: Although the high risk of postoperative endophthalmitis in cases of posterior capsular rupture (PCR) has been well-known, no specific prophylaxis has been proposed. In recent years, the safety of intracamer...

Cytomegalovirus Retinitis: Current State in People with HIV-AIDS in Peru

Purpose: To describe the incidence and progression of cytomegalovirus retinitis (CMVR) in public hospital patients from Peru. Study Design: Prospective study conducted in HIV-AIDS diagnosed patients. Place and Duration o...

To Assess the Effect of Lighting on Identifying the Ishihara Colour Vision Plates in Trichromats

Aims: The main aim of present study is to investigate the effect of luminance on identifying the Ishihara colour vision plates in normal trichromats. Place and Duration of Study: Dr. Rishi Bhardwaj Visual Psychophysics l...

Repeated Intravitreal Bevacizumab Injections versus Single Combined Intravitreal Bevacizumab and Posterior Subtenon Triamcinolone Injections for Treatment of Diabetic Macular Edema

Aim: To compare efficacy of combined intravitreal bevacizumab and subtenon triamcinolone versus three intravitreal injections of bevacizumab at one month interval for reducing foveal thickness. Methods: Sixty eyes of 30...

Download PDF file
  • EP ID EP338952
  • DOI 10.9734/OR/2014/7224
  • Views 115
  • Downloads 0

How To Cite

H. A. M. Mucke, E. Mucke, P. M. Mucke (2014). Aldose Reductase Inhibitors for Diabetic Cataract: A Study of Disclosure Patterns in Patents and Peer Review Papers. Ophthalmology Research: An International Journal, 2(3), 137-149. https://europub.co.uk/articles/-A-338952